Reports from Houston Methodist Research Institute Advance Knowledge in Tuberculosis (Cd44 Receptor Targeted Nanoparticles Augment Immunity Against Tuberculosis In Mice)

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Source:
    Vaccine Weekly. October 12, 2022, 120